Will Lewis, CEO of New Jersey-based Insmed Incorporated, believes this year will be transformational for the company, not least because it has several parallel late-stage clinical programs reaching maturation.
“We’re stacking a lot of events on top of each other that are quite significant for the company,” Lewis told...